3.15
+0.035(+1.13%)
Currency In USD
Address
Three Bala Plaza East
Bala Cynwyd, PA 19004
United States of America
Phone
844 511 9056
Website
Sector
Healthcare
Industry
Biotechnology
Employees
65
First IPO Date
June 19, 2014
| Name | Title | Pay | Year Born |
| Dr. Carole S. Ben-Maimon M.D. | Chief Executive Officer, President & Director | 905,658 | 1959 |
| Dr. Gopi Shankar M.B.A., Ph.D. | Chief Development Officer | 618,664 | 1971 |
| Mr. Michael Celano CPA | Secretary & Chief Financial Officer | 625,729 | 1959 |
| Dr. Russell G. Clayton Sr., D.O, D.O. | Chief Medical Officer | 0 | 1961 |
| Ms. Jennifer Spokes Johansson | Vice President of Legal & Compliance | 0 | N/A |
| Mr. John Berman | Vice President of Finance & Administration | 0 | N/A |
| Mr. Francis Michael Conway CPA | Vice President & Controller | 0 | N/A |
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.